Capital Increase 2017

4SC AG resolved to conduct a cash capital increase to raise funds to continue to advance its drug development programs for resminostat, 4SC-202 and 4SC-208.

Read more

Media Center

Corporate News
Ad Hoc Announcements
Photos & Logo

Presentations

Latest company presentations

Investor Information

4SC Share
Shareholder Structure
Financial Calendar
Financial Reports
Key Figures
Conference Calls & Webcasts
Analyst Coverage

Conference Calendar

Conferences with participation of 4SC

Read more

Shareholders’ Meetings

For more information please visit our

German website

Corporate Governance

Information on corporate governance at 4SC

Read more

Info Request & Email Alerts

Contact us directly or subscribe for our email alerts and receive up-to-date information.

Subscription